Literature DB >> 15864645

Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.

Jian Zhou1, Yong-Sheng Xiao, Zhao-You Tang, Jia Fan, Zhi-Quan Wu, Yan Zhao, Qiong Xue, Zao-Zhuo Shen, Yin-Kun Liu, Sheng-Long Ye.   

Abstract

PURPOSE: To investigate the effects on sensitivity to fluoropyrimidine and endothelial cell (EC) migration by transfection with thymidine phosphorylase (TP) cDNA to a hepatocellular carcinoma (HCC) cell line SMMC-7721.
METHODS: SMMC-7721 was transfected with pcDNA3.1/zeo (+) with human TP cDNA. TP mRNA expression was determined by RT-PCR. Sensitivity to fluoropyrimidine was determined by 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyl-tetrazolium bromide (MTT) assay. Induction of EC migration was detected by Boyden chamber assay.
RESULTS: The construction of pcDNA3.1/zeo(+)-TP was verified by digestion with restriction endonuclease Apa1. When comparison was made between SMMC-7721 cell clone transfected with pcDNA3.1/zeo(+)-TP (S-TP) and control clone transfected with pcDNA3.1/zeo(+) (S-vector), we found that TP mRNA expression level was much higher in S-TP, being 2.09+/-0.16 vs 0.48+/-0.06 in S-vector (P < 0.01), sensitivity to 5'-deoxy-5-fluorouridine (5'-dFUrd, a prodrug of 5-fluorouracil) in S-TP was significantly enhanced compared with that in S-vector (IC(50); 56.81+/-9.85 micromol/l vs 162.25+/-11.03 micromol/l, P < 0.01), and the culture medium of S-TP possessed more potential to induce EC migration than that of S-vector (the number of ECs appearing on the outer surfaces of the membrane was 275+/-29 vs 122+/-35 per field, P < 0.01).
CONCLUSION: Sensitivity to 5'-dFUrd could be enhanced by transfection with TP cDNA for SMMC-7721 cells. However, EC migration was also promoted at the same time. Therefore, transfection with TP alone might have no potential to enhance anti-tumoral effects of fluoropyrimidine in HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864645     DOI: 10.1007/s00432-005-0669-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.

Authors:  T Morita; A Matsuzaki; A Tokue
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

Review 2.  Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

Authors:  A W Griffioen; G Molema
Journal:  Pharmacol Rev       Date:  2000-06       Impact factor: 25.468

3.  Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells.

Authors:  M Ueda; Y Terai; K Kumagai; K Ueki; M Kanemura; M Ueki
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

4.  Trends in primary liver cancer.

Authors:  S Deuffic; T Poynard; L Buffat; A J Valleron
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

5.  Role of thymidine phosphorylase in biomodulation of fluoropyrimidines.

Authors:  T Morita; A Matsuzaki; K Suzuki; A Tokue
Journal:  Curr Pharm Biotechnol       Date:  2001-09       Impact factor: 2.837

6.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

Review 7.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

Authors:  N S Brown; R Bicknell
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

8.  Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.

Authors:  Ryungsa Kim; Shigeru Murakami; Tetsuya Toge
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

9.  Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.

Authors:  K Miyadera; T Sumizawa; M Haraguchi; H Yoshida; W Konstanty; Y Yamada; S Akiyama
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

10.  Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.

Authors:  S Marchetti; M Chazal; A Dubreuil; J L Fischel; M C Etienne; G Milano
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  2 in total

1.  Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Banchob Sripa; Chawalit Pairojkul; Srisurang Tantimavanich; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways.

Authors:  Qiong Wei; Haijuan Liu; Honghao Zhou; Dejun Zhang; Zhiwei Zhang; Qibing Zhou
Journal:  BMC Cancer       Date:  2015-03-21       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.